Technical document

Technical document: Introducing: Ami Polymer’s Sterile Sampling Systems

Published: 11 September 2023

Share this post

[easy-total-shares align="center" share_text="" url="https://www.europeanpharmaceuticalreview.com/whitepaper/186549/technical-document-introducing-ami-polymers-sterile-sampling-systems/"][easy-social-share buttons="facebook,twitter,linkedin,print,mail,more" morebutton="2" morebutton_icon="plus" counters=0 style="icon" column="yes" columns="3" url="https://www.europeanpharmaceuticalreview.com/whitepaper/186549/technical-document-introducing-ami-polymers-sterile-sampling-systems/" text="Technical document: Introducing: Ami Polymer’s Sterile Sampling Systems"]

Next-Gen Sterile Sampling System: Pinnacle Compliance – USP Standards 87, 88, 85, 661.1, 788, 71, and ISO 11737-1 for Unparalleled Pharma & Biopharma

Sterile sampling system is a critical component in the pharma and biopharma industries to ensure the safety, quality and integrity of products during their manufacturing processes. It involves aseptic collection of samples from various stages of production, such as raw materials, intermediates, final products, and environmental monitoring with Pharmacopoeia compliance and Biocompatibility which is highly recommended for critical applications with a wide range of sampling unit values 50 – 1000.